Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden
NCT03315962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 163
Last updated 2025-06-18
Summary
The overall objective of this study is to determine if a multi-component implementation intervention (SPIRIT) and additional leadership and management training that targets District Health Officers (DHOs) can increase IPT initiation among HIV-infected persons, as compared to country standard practices, in a cluster randomized trial in Uganda.
Conditions
Interventions
- BEHAVIORAL
-
SPIRIT Intervention
The intervention will include implementing a teaching collaborative among group of DHOs and TB Supervisors, enabling text messaging between DHOs and front line providers, and establishing a report collaborative where DHOs will receive feedback on the performance of their district in administering IPT compared to other districts.
Sponsors & Collaborators
-
Makerere University
collaborator OTHER -
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
Cipla Ltd.
collaborator INDUSTRY -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Diane Havlir, MD · University of California, San Francisco
-
Gabriel Chamie, MD, MPH · University of California, San Francisco
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-15
- Primary Completion
- 2023-11-30
- Completion
- 2023-11-30
Countries
- Uganda
Study Locations
More Related Trials
-
Pharmacogenetics-guided Isoniazid Dosing in TB-HIV
NCT05124678 ·Status: UNKNOWN ·Phase: PHASE2
-
Integrated Infectious Disease Capacity-Building Evaluation
NCT01190540 ·Status: COMPLETED ·Phase: NA
-
Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
NCT07119359 ·Status: RECRUITING ·Phase: NA
-
Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
NCT01433796 ·Status: COMPLETED
-
International HIV Antiretroviral Adherence, Resistance and Survival
NCT01596322 ·Status: COMPLETED
-
Interrupting HIV and TB Stigma in the Household in Uganda
NCT05124665 ·Status: COMPLETED ·Phase: NA
-
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
NCT01957865 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya
NCT05498727 ·Status: COMPLETED
-
Test and Treat TB: A Proof of Concept Trial in South Africa
NCT02298309 ·Status: COMPLETED ·Phase: NA
-
Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
NCT00463086 ·Status: COMPLETED ·Phase: NA
-
Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV
NCT02043067 ·Status: COMPLETED
-
Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals
NCT00865826 ·Status: COMPLETED
-
TB Reduction Through ART and TB Screening Project
NCT03739736 ·Status: UNKNOWN
-
Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)
NCT03302299 ·Status: COMPLETED ·Phase: PHASE4
-
Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia
NCT01252537 ·Status: COMPLETED
-
Scaling up TB and HIV Treatment Integration
NCT02654613 ·Status: COMPLETED ·Phase: NA
-
REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment
NCT01380080 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
NCT00078247 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive Individuals
NCT02980016 ·Status: COMPLETED ·Phase: PHASE3
-
Prevent TB: Choice Architecture for TPT Delivery
NCT04466488 ·Status: COMPLETED ·Phase: NA
-
ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study)
NCT01926379 ·Status: COMPLETED ·Phase: NA
-
A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV
NCT03154320 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes
NCT01782950 ·Status: UNKNOWN ·Phase: PHASE4
-
Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children (TB-Speed HIV)
NCT04121026 ·Status: COMPLETED ·Phase: NA
-
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
NCT05342064 ·Status: RECRUITING ·Phase: NA